
Peter Rothschild, CEO of BioGaia, summarizes the first quarter of 2013 and answers to questions regarding why sales in the U.S. and Asia has declined, status on the cooperation with Gerber, how the collaboration with Nestlé progresses and the status of the company’s studies within Helicobacter pyloriinfection and diabetes.